Phibro Animal Health | PAHC - Operating Expenses


Phibro Animal Health reported $361.83M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Align Technology USD 864.87M 2.84M Jun/2026
ANI Pharmaceuticals USD 597.21M 34.91M Jun/2026
Aurora Cannabis CAD 48.04M 81.94M Mar/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Canopy Growth CAD 98.72M 11.51M Mar/2026
Corcept Therapeutics USD 214.85M 343K Jun/2026
Eli Lilly USD 10.52B 496M Jun/2026
Henry Schein USD 3.26B 84M Jun/2026
Idexx Laboratories USD 791.02M 12.78M Jun/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Merck USD 15.77B 2.4B Jun/2026
Nektar Therapeutics USD 49.12M 8.22M Mar/2026
Pacira USD 180.54M 7.79M Jun/2026
Phibro Animal Health USD 361.83M 29.47M Mar/2026
Prestige Brands USD 213.19M 7.06M Jun/2026
Supernus Pharmaceuticals USD 1.03B 45.58M Jun/2026
Zoetis USD 3.15B 85M Jun/2026